Quinsam Capital (QCA) Q3 2024 earnings summary

Executive summary

• Achieved a profitable third quarter with net income of $1.2 million ($0.013 per share), up from $0.1 million ($0.001 per share) in Q3 2023, primarily driven by a tripling in California Nanotechnologies' value and positive contributions from Givex.

• Net assets stood at approximately $0.14 per share as of September 30, 2024.

• Liquid investments, including cash and public equities, totaled about $0.06 per share.

• Above Food, a private investment, underperformed due to delayed listing and cooling interest in alternative food markets.

• Cost reduction initiatives are expected to lower annual expenses by over $100,000.

Financial highlights

• Net income rose to $1.2 million in Q3 2024 from $0.1 million in Q3 2023.

• Added over CAD 1 million to liquid assets during the quarter.

• Realized cost reductions exceeding CAD 100,000, with further savings expected in Q4 and beyond.

• Over 1.45 million shares repurchased in Q3 2024 under the issuer bid.

• No income tax payable due to tax loss carryforwards; capital losses are the primary tax asset.

Outlook and guidance

• Optimistic about long-term prospects for California Nanotechnologies, despite a recent price dip heading into Q4.

• Expecting increased liquidity from private holdings as several are progressing toward public listings or refinancing.

• Management continues to seek value-creating, cash-neutral or positive transactions, anticipating a patient approach due to few new listings.